Analytical Data
-
Gene name
Statherin / STATH
- Application
-
Alternative Names
Statherin / STATH；
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P02808-1
-
Expression Region
1-62aa
-
AA Sequence
MKFLVFAFIL ALMVSMIGAD SSEEKFLRRI GRFGYGYGPY QPVPEQPLYP QPYQPQYQQY TF
-
Molecular Weight
32 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Statherin, a naturally occurring protein, plays a crucial role in oral biology and mineralization processes. It is primarily secreted by salivary glands and is known for its ability to stabilize calcium and phosphate ions, thereby preventing mineral loss and promoting remineralization in dental enamel. The protein’s unique structure, characterized by a high content of charge and hydrophilic residues, enables it to adhere to hydroxyapatite surfaces, which is central to its function in oral health. Research on recombinant statherin (STATH) has gained attention due to its potential applications in various fields, including dentistry and biomaterials. By producing a recombinant form of statherin, scientists aim to explore its properties more thoroughly and leverage its capabilities to develop innovative treatments for dental caries and other calcification-related conditions. Additionally, understanding the molecular mechanisms behind statherin’s activity can aid in designing effective strategies for enhancing the remineralization of affected teeth. As a result, studies on STATH not only provide insights into fundamental biological processes but also open avenues for developing therapeutic agents that could significantly improve oral health outcomes.
